Pegah Johansson1, Anders Fasth2, Torben Ek3, Ola Hammarsten1. 1. Department of Clinical Chemistry and Transfusion Medicine, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. 2. Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden. 3. Department of Pediatrics, Hospital of Halland, Halmstad, Sweden.
Abstract
BACKGROUND: The nucleosomal histone protein H2AX is specifically phosphorylated (γ-H2AX) adjacent to DNA double-strand breaks (DSBs) and is used for quantifying DSBs. Many chemotherapies and ionizing radiation (IR) used in cancer treatment result in DSBs. Therefore, γ-H2AX has a significant potential as a biomarker in evaluating patient sensitivity and responsiveness to IR and chemotherapy. METHODS: Here, we report a flow cytometry-based quantification of γ-H2AX (FCM-γ-H2AX assay) customized for clinical practice. RESULTS: We validated that our method is able to detect DNA damage in peripheral blood mononuclear cells (PBMCs) treated with DSB inducing agents. The method also detected the DNA repair deficiency in PBMCs treated with DNA repair inhibitors, as well as the deficiency in DNA repair signaling in PBMCs from two ataxia telangiectasia patients. CONCLUSIONS: The FCM-γ-H2AX assay has sufficient analytical sensitivity and precision to measure levels of DNA damage and DNA repair for clinical purposes.
BACKGROUND: The nucleosomal histone protein H2AX is specifically phosphorylated (γ-H2AX) adjacent to DNA double-strand breaks (DSBs) and is used for quantifying DSBs. Many chemotherapies and ionizing radiation (IR) used in cancer treatment result in DSBs. Therefore, γ-H2AX has a significant potential as a biomarker in evaluating patient sensitivity and responsiveness to IR and chemotherapy. METHODS: Here, we report a flow cytometry-based quantification of γ-H2AX (FCM-γ-H2AX assay) customized for clinical practice. RESULTS: We validated that our method is able to detect DNA damage in peripheral blood mononuclear cells (PBMCs) treated with DSB inducing agents. The method also detected the DNA repair deficiency in PBMCs treated with DNA repair inhibitors, as well as the deficiency in DNA repair signaling in PBMCs from two ataxia telangiectasiapatients. CONCLUSIONS: The FCM-γ-H2AX assay has sufficient analytical sensitivity and precision to measure levels of DNA damage and DNA repair for clinical purposes.
Authors: Martin Fasshauer; Thomas Krüwel; Antonia Zapf; Vera C Stahnke; Margret Rave-Fränk; Wieland Staab; Jan M Sohns; Michael Steinmetz; Christina Unterberg-Buchwald; Andreas Schuster; Christian Ritter; Joachim Lotz Journal: Eur Radiol Date: 2017-10-06 Impact factor: 5.315
Authors: Joy E Garrett; Erin Metzger; Katelyn Schmitt; Sarai Soto; Samantha Northern; Laura Kryah; Misbah Irfan; Susan Rice; Mary Brown; Jeffrey M Zaleski; Joseph R Dynlacht Journal: Radiat Res Date: 2019-12-04 Impact factor: 2.841
Authors: Angel Y F Kam; Sadhna O Piryani; Chad M McCall; Hee Su Park; David A Rizzieri; Phuong L Doan Journal: Clin Cancer Res Date: 2019-04-05 Impact factor: 12.531
Authors: John Heath; Estelle Simo Cheyou; Steven Findlay; Vincent M Luo; Edgar Pinedo Carpio; Jeesan Lee; Billel Djerir; Xiaoru Chen; Théo Morin; Benjamin Lebeau; Martin Karam; Halil Bagci; Damien Grapton; Josie Ursini-Siegel; Jean-Francois Côté; Michael Witcher; Stéphane Richard; Alexandre Maréchal; Alexandre Orthwein Journal: EMBO Rep Date: 2021-11-10 Impact factor: 9.071
Authors: Chiara Grasselli; Silvia Bombelli; Stefano Eriani; Giulia Domenici; Riccardo Galluccio; Chiara Tropeano; Sofia De Marco; Maddalena M Bolognesi; Barbara Torsello; Cristina Bianchi; Laura Antolini; Fabio Rossi; Paolo Mazzola; Valerio Leoni; Giuseppe Bellelli; Roberto A Perego Journal: J Gerontol A Biol Sci Med Sci Date: 2022-07-05 Impact factor: 6.591